Nassau, Bahamas – Oceanside Treatment Center, a leading addiction recovery facility located in Nassau is proud to announce the results of a significant research study conducted on 28 clients struggling with fentanyl addiction. The study, which took place over a 12-month period from November 15, 2023, to November 15, 2024, demonstrates the effectiveness of Oceanside's specialized Ibogaine treatment protocols in helping clients break free from opioid addiction. This study underscores the center's commitment to advancing addiction recovery through innovative therapies and data-driven insights.

The research study, a single-group experimental study, focused on assessing the impact of Ibogaine treatment on fentanyl addiction. In a single-group experimental study, all participants receive the same treatment, and the results are observed and analyzed over time to evaluate the effectiveness of the intervention. Throughout the study, clients, aged between 30 and 56 years, received Ibogaine treatment in combination with Oceanside's customized aftercare therapies, tailored to meet their individual needs. Each client also participated in co-therapy sessions designed to address mental health challenges, which are often present alongside addiction.

The findings from this study are promising: at the conclusion of the 12-month period, 23 out of the 28 participants remained opiate-free. This success rate demonstrates the positive impact of Ibogaine therapy and the holistic, personalized treatment approaches employed at Oceanside Treatment Center. The study was conducted and analyzed by Oceanside’s experienced clinical team, and the data collected is integral to the center's ongoing commitment to quality control and continuous improvement in treatment protocols.

At Oceanside Treatment Center, we place great emphasis on research and data collection to ensure the highest standards of care and the most effective treatment for our clients. This study provides valuable insights that will help refine and advance our addiction recovery programs. As we continue to lead the way in innovative treatments for opioid addiction, we believe that this research will help extend our success to even more individuals, both in the Bahamas and globally.

Completion Statement
Oceanside Ibogaine Treatment Center remains steadfast in its mission to provide exceptional care for individuals struggling with addiction, and this study is just one example of our commitment to innovation and results. As we continue to use data and research to enhance our treatment protocols, we are confident that our work will have a lasting, positive impact on addiction recovery worldwide. We look forward to building on these findings and offering even more individuals the opportunity to achieve lasting, life-changing recovery.

Contact Details;
Oceanside Treatment Center
Admission Email - [email protected]
Address: Nassau Bahamas
Toll Free: 1-800-846-0038